Low-Dose Irinotecan Improves Advanced Lupus Nephritis in Mice Potentially by Changing DNA Relaxation and Anti-Double-Stranded DNA Binding-Reference-Cited by-同舟云学术

Low-Dose Irinotecan Improves Advanced Lupus Nephritis in Mice Potentially by Changing DNA Relaxation and Anti-Double-Stranded DNA Binding

Published:2014-07-28 Issue:8 Volume:66 Page:2259-2269
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Frese-Schaper Manuela¹,Keil Andreas¹,Steiner Selina K.¹,Gugger Mathias²,Körner Meike²,Kocher Gregor J.¹,Schiffer Lena³,Anders Hans-Joachim⁴,Huynh-Do Uyen¹,Schmid Ralph A.¹,Frese Steffen¹

Affiliation:

1. University Hospital Bern; Bern Switzerland

2. Institute of Pathology, University of Bern; Bern Switzerland

3. Hannover Medical School; Hannover Germany

4. Medizinische Klinik und Poliklinik IV and University of Munich; Munich Germany

Funder

Swiss National Science Foundation

Albert Bï¿½ni Foundation

Kurt and Senta Herrmann-Foundation

Olga Mayenfisch Foundation

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.38665/fullpdf

Reference51 articles.

1. Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA;Hochberg;Lupus,1995

2. Treatment of proliferative lupus nephritis: a slowly changing landscape;Tesar;Nat Rev Nephrol,2011

3. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients;Cervera;Medicine (Baltimore),2003

4. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus;Mok;Arthritis Rheum,2013

5. What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials?;Clark;Clin J Am Soc Nephrol,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis;Kidney International Reports;2024-06

2. Transcription Factors in the Pathogenesis of Lupus Nephritis and Their Targeted Therapy;International Journal of Molecular Sciences;2024-01-16

3. Apigenin Synergizes with Irinotecan in Inducing the Immunogenic Effects in Colorectal Cancer;2024

4. Increased binding of anti-dsDNA antibodies to short oligonucleotides modified with topoisomerase I reveals a potential new enzyme function independent from DNA relaxation;BMC Research Notes;2023-10-28

5. Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy;Scandinavian Journal of Rheumatology;2021-11-02